BioMarin Pharmaceutical Inc. buy StockNews.com
Start price
02.03.25
/
50%
€67.70
Target price
02.03.26
-
Performance (%)
-25.47%
End price
03.03.26
€50.46
Summary
This prediction ended on 03.03.26 with a price of €50.46. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -25.47%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -3.031% | -3.031% | -10.521% |
| iShares Core DAX® | 4.244% | 2.864% | 14.030% |
| iShares Nasdaq 100 | 4.890% | 2.814% | 32.707% |
| iShares Nikkei 225® | 9.397% | 7.826% | 48.296% |
| iShares S&P 500 | 3.528% | 1.950% | 25.247% |
Comments by StockNews_com for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€66.60
10.03.25
10.03.25
-
10.03.26
10.03.26
-21.50%
11.03.26
11.03.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€65.26
22.02.25
22.02.25
-
22.02.26
22.02.26
-17.99%
23.02.26
23.02.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€88.08
29.04.23
29.04.23
-
29.04.24
29.04.24
-13.03%
30.04.24
30.04.24